Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Xillix

This article was originally published in The Gray Sheet

Executive Summary

Xillix: Completes second and final closing of its $7 mil. private placement, announced in late February ("The Gray Sheet" March 6, p. 16). Richmond, British Columbia-based Xillix, a cancer imaging products manufacturer, says the second closing related to the sale of 715,000 special warrants to the Working Opportunity Fund for about $700,000. The Fund was founded by the British Columbia government to invest in local firms. Xillix announced previously its placement of about 6 mil. special warrants, raising $6.3 mil. in gross proceeds ("The Gray Sheet" March 20, p. 12)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel